IBDEI0PZ ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26114,1,3,0)
 ;;=3^Psytx 38-52 min;Report w/ E&M
 ;;^UTILITY(U,$J,358.3,26115,0)
 ;;=90838^^98^1239^3^^^^1
 ;;^UTILITY(U,$J,358.3,26115,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26115,1,2,0)
 ;;=2^90838
 ;;^UTILITY(U,$J,358.3,26115,1,3,0)
 ;;=3^Psytx 53-89 min;Report w/ E&M
 ;;^UTILITY(U,$J,358.3,26116,0)
 ;;=90853^^98^1240^4^^^^1
 ;;^UTILITY(U,$J,358.3,26116,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26116,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,26116,1,3,0)
 ;;=3^Group Psychotherapy
 ;;^UTILITY(U,$J,358.3,26117,0)
 ;;=90846^^98^1240^5^^^^1
 ;;^UTILITY(U,$J,358.3,26117,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26117,1,2,0)
 ;;=2^90846
 ;;^UTILITY(U,$J,358.3,26117,1,3,0)
 ;;=3^Family Psychotherapy w/o pt.
 ;;^UTILITY(U,$J,358.3,26118,0)
 ;;=90847^^98^1240^6^^^^1
 ;;^UTILITY(U,$J,358.3,26118,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26118,1,2,0)
 ;;=2^90847
 ;;^UTILITY(U,$J,358.3,26118,1,3,0)
 ;;=3^Family Psychotherpy w/pt.
 ;;^UTILITY(U,$J,358.3,26119,0)
 ;;=90875^^98^1240^7^^^^1
 ;;^UTILITY(U,$J,358.3,26119,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26119,1,2,0)
 ;;=2^90875
 ;;^UTILITY(U,$J,358.3,26119,1,3,0)
 ;;=3^Indiv Psychophysiological Tx w/ Biofeedback,30 min
 ;;^UTILITY(U,$J,358.3,26120,0)
 ;;=90876^^98^1240^8^^^^1
 ;;^UTILITY(U,$J,358.3,26120,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26120,1,2,0)
 ;;=2^90876
 ;;^UTILITY(U,$J,358.3,26120,1,3,0)
 ;;=3^Indiv Psychophysiological Tx w/ Biofeedback,45 min
 ;;^UTILITY(U,$J,358.3,26121,0)
 ;;=90832^^98^1240^1^^^^1
 ;;^UTILITY(U,$J,358.3,26121,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26121,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,26121,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,26122,0)
 ;;=90834^^98^1240^2^^^^1
 ;;^UTILITY(U,$J,358.3,26122,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26122,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,26122,1,3,0)
 ;;=3^Psychotherapy 38-52 min
 ;;^UTILITY(U,$J,358.3,26123,0)
 ;;=90837^^98^1240^3^^^^1
 ;;^UTILITY(U,$J,358.3,26123,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26123,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,26123,1,3,0)
 ;;=3^Psychotherapy 53-89 min
 ;;^UTILITY(U,$J,358.3,26124,0)
 ;;=90849^^98^1240^9^^^^1
 ;;^UTILITY(U,$J,358.3,26124,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26124,1,2,0)
 ;;=2^90849
 ;;^UTILITY(U,$J,358.3,26124,1,3,0)
 ;;=3^Multiple Family Psychotherapy
 ;;^UTILITY(U,$J,358.3,26125,0)
 ;;=J1631^^98^1241^13^^^^1
 ;;^UTILITY(U,$J,358.3,26125,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26125,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,26125,1,3,0)
 ;;=3^Haloperidol Decanoate,per 50 mg
 ;;^UTILITY(U,$J,358.3,26126,0)
 ;;=97545^^98^1241^44^^^^1
 ;;^UTILITY(U,$J,358.3,26126,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26126,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,26126,1,3,0)
 ;;=3^Work Hardening/Conditioning,Init 2 hrs
 ;;^UTILITY(U,$J,358.3,26127,0)
 ;;=97546^^98^1241^45^^^^1
 ;;^UTILITY(U,$J,358.3,26127,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26127,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,26127,1,3,0)
 ;;=3^Work Hardening/Conditioning,ea addl hr
 ;;^UTILITY(U,$J,358.3,26128,0)
 ;;=97537^^98^1241^4^^^^1
 ;;^UTILITY(U,$J,358.3,26128,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26128,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,26128,1,3,0)
 ;;=3^Community/Work Reintegration ea 15 min by Phd/Phys
 ;;^UTILITY(U,$J,358.3,26129,0)
 ;;=97532^^98^1241^3^^^^1
 ;;^UTILITY(U,$J,358.3,26129,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26129,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,26129,1,3,0)
 ;;=3^Cognitive Skills Development,ea 15 min
 ;;^UTILITY(U,$J,358.3,26130,0)
 ;;=97533^^98^1241^32^^^^1
 ;;^UTILITY(U,$J,358.3,26130,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26130,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,26130,1,3,0)
 ;;=3^Sensory Integrative Techniques,per 15 min
 ;;^UTILITY(U,$J,358.3,26131,0)
 ;;=H0004^^98^1241^15^^^^1
 ;;^UTILITY(U,$J,358.3,26131,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26131,1,2,0)
 ;;=2^H0004
 ;;^UTILITY(U,$J,358.3,26131,1,3,0)
 ;;=3^Ind Counseling & Therapy,ea 15 min
 ;;^UTILITY(U,$J,358.3,26132,0)
 ;;=H0046^^98^1241^21^^^^1
 ;;^UTILITY(U,$J,358.3,26132,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26132,1,2,0)
 ;;=2^H0046
 ;;^UTILITY(U,$J,358.3,26132,1,3,0)
 ;;=3^PTSD Group
 ;;^UTILITY(U,$J,358.3,26133,0)
 ;;=96119^^98^1241^17^^^^1
 ;;^UTILITY(U,$J,358.3,26133,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26133,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,26133,1,3,0)
 ;;=3^Neuropsych Test Admin by tech,per hr w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26134,0)
 ;;=96402^^98^1241^16^^^^1
 ;;^UTILITY(U,$J,358.3,26134,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26134,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,26134,1,3,0)
 ;;=3^Injec,IM or SQ,anti-neplastic hormonal anti-neoplastic drug
 ;;^UTILITY(U,$J,358.3,26135,0)
 ;;=96102^^98^1241^25^^^^1
 ;;^UTILITY(U,$J,358.3,26135,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26135,1,2,0)
 ;;=2^96102
 ;;^UTILITY(U,$J,358.3,26135,1,3,0)
 ;;=3^Psych Test Admin by Tech,per hr w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26136,0)
 ;;=96103^^98^1241^23^^^^1
 ;;^UTILITY(U,$J,358.3,26136,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26136,1,2,0)
 ;;=2^96103
 ;;^UTILITY(U,$J,358.3,26136,1,3,0)
 ;;=3^Psych Test Admin by Computer w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26137,0)
 ;;=96120^^98^1241^18^^^^1
 ;;^UTILITY(U,$J,358.3,26137,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26137,1,2,0)
 ;;=2^96120
 ;;^UTILITY(U,$J,358.3,26137,1,3,0)
 ;;=3^Neuropsych Tst Admin by Computer w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26138,0)
 ;;=96125^^98^1241^34^^^^1
 ;;^UTILITY(U,$J,358.3,26138,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26138,1,2,0)
 ;;=2^96125
 ;;^UTILITY(U,$J,358.3,26138,1,3,0)
 ;;=3^Standardized Cognitive Performance Tst,per hr w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26139,0)
 ;;=96372^^98^1241^40^^^^1
 ;;^UTILITY(U,$J,358.3,26139,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26139,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,26139,1,3,0)
 ;;=3^Ther/Proph/Diag Inj,SC/IM
 ;;^UTILITY(U,$J,358.3,26140,0)
 ;;=Q3014^^98^1241^39^^^^1
 ;;^UTILITY(U,$J,358.3,26140,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26140,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,26140,1,3,0)
 ;;=3^Telehealth Facility Fee
 ;;^UTILITY(U,$J,358.3,26141,0)
 ;;=90889^^98^1241^22^^^^1
 ;;^UTILITY(U,$J,358.3,26141,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26141,1,2,0)
 ;;=2^90889
 ;;^UTILITY(U,$J,358.3,26141,1,3,0)
 ;;=3^Preparation of Report for Indiv/Agency/Insurance
 ;;^UTILITY(U,$J,358.3,26142,0)
 ;;=96118^^98^1241^19^^^^1
 ;;^UTILITY(U,$J,358.3,26142,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26142,1,2,0)
 ;;=2^96118
 ;;^UTILITY(U,$J,358.3,26142,1,3,0)
 ;;=3^Neuropsych Tst Admin by PhD/Phys,per hr w/ Interp & Rpt
 ;;^UTILITY(U,$J,358.3,26143,0)
 ;;=G0177^^98^1241^41^^^^1
 ;;^UTILITY(U,$J,358.3,26143,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26143,1,2,0)
 ;;=2^G0177
 ;;^UTILITY(U,$J,358.3,26143,1,3,0)
 ;;=3^Train & Ed for Disabiling MH Problem,45+ min
 ;;^UTILITY(U,$J,358.3,26144,0)
 ;;=J1630^^98^1241^14^^^^1
 ;;^UTILITY(U,$J,358.3,26144,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26144,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,26144,1,3,0)
 ;;=3^Haloperidol,Up to 5mg
 ;;^UTILITY(U,$J,358.3,26145,0)
 ;;=J2794^^98^1241^29^^^^1
 ;;^UTILITY(U,$J,358.3,26145,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26145,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,26145,1,3,0)
 ;;=3^Risperidone,Long Acting per 0.5mg
 ;;^UTILITY(U,$J,358.3,26146,0)
 ;;=99090^^98^1241^28^^^^1
 ;;^UTILITY(U,$J,358.3,26146,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26146,1,2,0)
 ;;=2^99090
 ;;^UTILITY(U,$J,358.3,26146,1,3,0)
 ;;=3^Record Review (Labs,Remote Data)
